NIH Study Links Abnormal Prenatal DNA Tests to Cancer Detection
NIH researchers found undetected cancers in nearly half of pregnant people with abnormal prenatal cfDNA test results.
Read MorePosted by Andy Lundin | Dec 4, 2024 | Cancer, Prenatal Testing |
NIH researchers found undetected cancers in nearly half of pregnant people with abnormal prenatal cfDNA test results.
Read MorePosted by Andy Lundin | Dec 3, 2024 | Lung Cancer, Molecular Diagnostics |
Studies validated Biofidelity’s Aspyre Lung diagnostic tech, showcasing its ability to offer genomic profiling for actionable NSCLC variants.
Read MorePosted by Chris Wolski | Nov 28, 2024 | Breast |
A researcher’s new mouse model for studying breast cancer could enhance understanding of cancer metastasis and its spread to organs.
Read MorePosted by Andy Lundin | Nov 12, 2024 | Lung Cancer |
A blood test identifies early lung damage in cancer patients taking antibody–drug conjugates, offering an alternative to imaging scans.
Read MorePosted by Andy Lundin | Nov 7, 2024 | Cancer |
Caris Life Sciences’ MI Cancer Seek CDx assay received FDA approval to help identify cancer patients who may benefit from targeted therapies.
Read More